mj option 2 thermal cycler (MJ Research)
90
Structured Review
MJ Research
mj option 2 thermal cycler
Mj Option 2 Thermal Cycler, supplied by MJ Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mj+option+2+thermal+cycler/dna+engine+option+2+thermal+cycler/pm21649545-80-13-18
Average 90 stars, based on 1 article reviews
Mj Option 2 Thermal Cycler, supplied by MJ Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mj+option+2+thermal+cycler/dna+engine+option+2+thermal+cycler/pm21649545-80-13-18
Average 90 stars, based on 1 article reviews
mj option 2 thermal cycler - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
cDNA Synthesis:Article Title: Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant. Article Snippet: Umbilical cord blood (UCB) is used increasingly as a source of hematopoietic cells because of a lower risk of graft-versushost disease (GVHD).. Myeloablative conditioning before allogeneic umbilical cord blood transplant (allo-UCBT) results in thymic epithelial cell injury and T-cell immune deficiency.. Full-term fetal blood cells were used as hematopoietic cells in a previous murine allo-UCBT model with a limited number of mice surviving the myeloablative conditioning. Synthesized:Article Title: Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant. Article Snippet: Umbilical cord blood (UCB) is used increasingly as a source of hematopoietic cells because of a lower risk of graft-versushost disease (GVHD).. Myeloablative conditioning before allogeneic umbilical cord blood transplant (allo-UCBT) results in thymic epithelial cell injury and T-cell immune deficiency.. Full-term fetal blood cells were used as hematopoietic cells in a previous murine allo-UCBT model with a limited number of mice surviving the myeloablative conditioning. Reverse Transcription:Article Title: Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant. Article Snippet: Umbilical cord blood (UCB) is used increasingly as a source of hematopoietic cells because of a lower risk of graft-versushost disease (GVHD).. Myeloablative conditioning before allogeneic umbilical cord blood transplant (allo-UCBT) results in thymic epithelial cell injury and T-cell immune deficiency.. Full-term fetal blood cells were used as hematopoietic cells in a previous murine allo-UCBT model with a limited number of mice surviving the myeloablative conditioning. Real-time Polymerase Chain Reaction:Article Title: Suppression of vascular endothelial growth factor (VEGF) expression by targeting the Bcr-Abl oncogene and protein tyrosine kinase activity in Bcr-Abl-positive leukaemia cells. Article Snippet: Studies have shown that vascular endothelial growth factor (VEGF), a major and potent inducer of angiogenesis, is directly triggered by the disease-related oncogene Bcr-Abl in Bcr-Abl-positive cells.. In this study, inhibition of Bcr-Abl tyrosine kinase activity by imatinib significantly decreased VEGF expression in Bcr-Ablpositive K562 cells in vitro.. Imatinib treatment in vivo of nude mice xenografted with K562 cells resulted in a significant reduction in tumour size and microvessel density compared with untreated tumours. Polymerase Chain Reaction:Article Title: Suppression of vascular endothelial growth factor (VEGF) expression by targeting the Bcr-Abl oncogene and protein tyrosine kinase activity in Bcr-Abl-positive leukaemia cells. Article Snippet: Studies have shown that vascular endothelial growth factor (VEGF), a major and potent inducer of angiogenesis, is directly triggered by the disease-related oncogene Bcr-Abl in Bcr-Abl-positive cells.. In this study, inhibition of Bcr-Abl tyrosine kinase activity by imatinib significantly decreased VEGF expression in Bcr-Ablpositive K562 cells in vitro.. Imatinib treatment in vivo of nude mice xenografted with K562 cells resulted in a significant reduction in tumour size and microvessel density compared with untreated tumours. |